Olanzapine for the Prevention of Postoperative Nausea and Vomiting

NCT04718727 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Postoperative Nausea

Interventions

DRUG: Placebo
DRUG: 5 mg Olanzapine Tablets
DRUG: 10 mg Olanzapine Tablets

Sponsor

Amani Hassan Abdel-Wahab